We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
The Path Forward: What’s On The Horizon?
Manesh R. Patel, MD
New Frontiers in Anticoagulation: Factor XI/XIa Inhibitors
Christopher B. Granger, MD
M. Cecilia Bahit, MD
Elaine Hylek, MD, MPH
While DOACs are Good for Some Things, They Are Not for Everyone
Questions & Answers from the AHA 2023 Symposium
The DOAC Revolution: What Have We Learned?
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
Experts Discuss Longevity and Durability with TAVR
Suzanne J. Baron, MD
Jonathan A. Bradlow, MD, FACC
Kendra J. Grubb, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education